Life Science Investor Services
Independent commercial insight for confident investment decisions, portfolio value creation and exit readiness.
What We Do
We help early-stage investors, venture capital, growth equity and private equity investors assess and rank opportunities across the life sciences and healthcare sector. Our work combines deep sector experience, market and regulatory understanding, founder, stakeholder and management engagement, and proven commercial judgement so investors can move quickly without losing sight of risk.
Who We Help
We help early-stage investors, venture capital, growth equity and private equity investors assess and rank opportunities across the life sciences and healthcare sector. Our work combines deep sector experience, market and regulatory understanding, founder, stakeholder and management engagement, and proven commercial judgement so investors can move quickly without losing sight of risk.
- Early-stage investors assessing spin-out scientific, clinical or platform opportunities
- VC and Growth Equity investors testing expansion plans, revenue assumptions and market readiness
- Private Equity investors reviewing commercial performance, scalability and value-creation potential
- Portfolio teams looking for practical support between investment and exit
Our Services
We provide focused support across the complete investor deal lifecycle, from first-look screening through due diligence, post-deal assessment & monitoring, value creation and exit scenario planning.
- Initial screening and opportunity assessment: fixed-price opinion pieces, founder & stakeholder interviews, opportunity-versus-risk assessment, market and adoption considerations, and clear go/no-go advice.
- Due diligence: expert review of market potential, market trends, competition, regulatory requirements, business plans, forecasts and commercial readiness.
- Post-deal assessment & monitoring: pots-close analysis of current situation vs. DD information, mentoring founders, C-suite teams and commercial teams, with practical challenge on activities, outcomes KPIs and milestones.
- Value creation: translating diligence findings into commercial priorities, action plans and investor-aligned milestones.
- Exit scenario planning: identifying the evidence, strategic positioning and buyer-facing narrative needed to support valuation and exit readiness.
Engagement Models
Our work can be tailored to the stage of the opportunity and the depth of analysis required. We can provide rapid screening input, structured diligence reports or ongoing portfolio support.
- Fixed-price screening: rapid first-look assessment to help investors decide whether to progress an opportunity.
- Tailored due diligence: deeper analysis calibrated to venture, growth equity or private equity requirements.
- Portfolio value-creation support: mentoring, commercial challenge and action planning after investment.
Why Investors Work With Us
Investors work with us because we combine sector-specific judgement with clear, practical outputs. We challenge assumptions, highlight both upside and risk, and help translate complex scientific and commercial information into investor-ready conclusions.
- Independent perspective: wholly objective advice designed to test assumptions and identify risk.
- Life sciences & healthcare focus: understanding of scientific, regulatory, market and commercial drivers.
- Practical outputs: concise written reports and Q& A sessions, clear fact based recommendations and decision-focused conclusions & support.
Contact
If you are reviewing a life science or healthcare sector investment, preparing for diligence or looking to accelerate portfolio value creation, we can provide focused, independent support. Contact us to discuss the opportunity, the decision you need to make, and the level of review required. management engagement, and proven commercial judgement so investors can move quickly without losing sight of risk.